Why is ERIS Lifescience falling/rising?

As of 12-Aug, ERIS Lifesciences Ltd is experiencing a decline in its stock price, currently at Rs 1,680.00, which reflects a decrease of Rs 38.9 or 2.26%. Today's price summary indicates that the stock has underperformed its sector by 2.64% and has fallen after two consecutive days of gains, reaching an intraday low of Rs 1,666.65. The stock's performance over the past week shows a decline of 7.13%, while it has still managed to generate a positive return of 22.73% year-to-date and 39.40% over the last year, outperforming the BSE500 index consistently in recent years. Despite high management efficiency and strong financial metrics, including a low Debt to EBITDA ratio and high institutional holdings, the recent drop may be attributed to falling investor participation, as evidenced by a 4.93% decrease in delivery volume compared to the five-day average.
In the broader market context, the stock's short-term performance has significantly lagged behind the benchmark, with a 1-week decline of 7.13% compared to the Sensex's modest drop of 0.59%. This underperformance in the short term, coupled with a trend reversal after previous gains, suggests that market sentiment may be shifting negatively for ERIS Lifesciences Ltd. While the company has shown strong fundamentals and consistent returns over the past three years, the current market dynamics and reduced trading activity could be contributing to the stock's recent price decline.